Ask AI

Equity and Shared Decision-making in Myelofibrosis

Text Module
Text Module Start Activity
This activity is available for 0.25 CME/CE credit(s).

Released: October 20, 2026

Expiration: April 19, 2027

See Activity Collection

Providing equitable, patient-centered care in myelofibrosis requires addressing the complex interplay of patient, disease, treatment, and health system factors that influence outcomes. In this text module, expert faculty explore practical strategies to advance equitable, patient-centered myelofibrosis care by addressing barriers to treatment access, incorporating symptom and quality-of-life assessment, strengthening shared decision-making and patient–provider communication, and leveraging multidisciplinary collaboration to support individualized treatment goals and improve patient experience.

Equity and SDM in MF

Pre Assessment

Assess your current knowledge and clinical approach before beginning your text module.
1.

How many people with MF do you provide care for in a typical month?​

2.

For those who practice in academic or community settings, please indicate your practice setting:

3.

Your patient with MF receives care at a community practice located 2 hours from an academic myeloproliferative neoplasm (MPN) center. The patient has good symptom control on the current therapy but develops worsening anemia, and transportation limitations make frequent travel difficult. Which approach would best support equitable, coordinated care?